HDL cholesterol: physiology, pathophysiology, and management.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current problems in cardiology

• Publication date

  2007-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CPCARDIOL.2007.01.004PMID 17481993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol Absorption Inhibitors for the Treatment of Hypercholesterolaemia

  2012cited by this paper
• Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.

  2006cited by this paper
• Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome

  2006cited by this paper
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actions⃞

  2006cited by this paper
• Adult Weight Change and Risk of Postmenopausal Breast Cancer

  2006cited by this paper
• Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

  2005cited by this paper
• Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia.

  2005cited by this paper
• Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.

  2005cited by this paper
• Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

  2005cited by this paper
• Evidence of major genes for plasma HDL, LDL cholesterol and triglyceride levels at baseline and in response to 20 weeks of endurance training: the HERITAGE Family Study.

  2005cited by this paper
• High-density lipoprotein function recent advances.

  2005cited by this paper
• Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

  2005cited by this paper
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

  2005cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators

  2005cited by this paper
• Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

  2005cited by this paper
• Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

  2005cited by this paper
• A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical Events

  2005cited by this paper
• A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.

  2005cited by this paper
• The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.

  2004cited by this paper
• Are the effects of statins on HDL-cholesterol clinically relevant?

  2004cited by this paper
• Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

  2004cited by this paper
• ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

  2004cited by this paper
• Dyslipidemia management in adults with diabetes.

  2004cited by this paper
• Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

  2004cited by this paper
• Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol.

  2004cited by this paper
• Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

  2004cited by this paper
• Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial

  2004cited by this paper
• Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

  2004cited by this paper
• Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The Prospective EPIC (European Prospective Investigation into Cancer and nutrition)–Norfolk Population Study

  2004cited by this paper
• Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal

  2004cited by this paper
• Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200

  2004cited by this paper
• Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins

  2004cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004cited by this paper
• Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib

  2004cited by this paper
• Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

  2004cited by this paper
• Thiazolidinediones.

  2004cited by this paper
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

  2003cited by this paper
• Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial

  2003cited by this paper
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

  2003cited by this paper
• Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol

  2003cited by this paper
• Effects of extended-release niacin on lipoprotein subclass distribution.

  2003cited by this paper
• The safety and immunogenicity of a CETP vaccine in healthy adults.

  2003cited by this paper
• Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.

  2003cited by this paper
• Niacin-ER and Lovastatin Treatment of Hypercholesterolemia and Mixed Dyslipidemia

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Coronary Heart Disease in Patients With Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Isolation and Characterization of the Putative Nuclear Modifier Gene MTO1 Involved in the Pathogenesis of Deafness-associated Mitochondrial 12 S rRNA A1555G Mutation*

  2002cited by this paper
• Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner*

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study

  2002cited by this paper
• Inspection of the reversal of enantiomer migration order in ligand exchange micellar electrokinetic capillary chromatography.

  2001cited by this paper
• High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization

  2001cited by this paper
• Cardiovascular Status of Carriers of the Apolipoprotein A-IMilano Mutant: The Limone sul Garda Study

  2001cited by this paper
• Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus.

  2001cited by this paper
• HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

  2001cited by this paper
• Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation

  2001cited by this paper
• PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

  2001cited by this paper
• Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids*

  2001cited by this paper
• The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease.

  2001cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

  2001cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

  2001cited by this paper
• Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.

  2000cited by this paper
• Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

  2000cited by this paper
• A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

  2000cited by this paper
• Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

  2000cited by this paper
• Nonpharmacologic management of low levels of high-density lipoprotein cholesterol.

  2000cited by this paper
• Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.

  2000cited by this paper
• Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project

  2000cited by this paper
• Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.

  2000cited by this paper
• PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

  2000cited by this paper
• Role of fibrates in the management of hypertriglyceridemia.

  1999cited by this paper
• Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice.

  1999cited by this paper
• Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

  1999cited by this paper
• Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

  1999cited by this paper
• New perspectives on the management of low levels of high-density lipoprotein cholesterol.

  1999cited by this paper
• Oxidized LDL and atherogenesis.

  1999cited by this paper
• Scavenger receptor BI and cholesterol trafficking.

  1999cited by this paper
• Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.

  1999cited by this paper
• Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.

  1999cited by this paper
• Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

  1999cited by this paper
• Role of exercise and weight loss in maximizing LDL cholesterol reduction

  1999cited by this paper
• Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.

  1999cited by this paper
• High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

  1999cited by this paper

• In situ NMR and integrative proteomics reveal the interaction signature of serum α-synuclein.

  2026cites this paper
• The moderating role of walking in the association between HDL cholesterol and cognitive function among Korean older adults: a nationwide population-based cross-sectional study

  2025cites this paper
• Valorization of orange seeds oil as a health-promoting ingredient in functional mayonnaise production

  2025cites this paper
• Metabolomics Profiling of Epicardial Adipose Tissue: MESA and the Rotterdam Study

  2025cites this paper
• Effect of Ezetimibe and Simvastatin Therapy in Subjects with Hyperlipidemia on Ankle Brachial Index, High Sensitive C Reactive Protein and Carotid Intima Media Thickness

  2024cites this paper
• Incidence and predictors of chronic kidney disease among patients with diabetes treated at governmental hospitals of Harari Region, eastern Ethiopia, 2022

  2024cites this paper
• The Impact of 24 h Urinary Potassium Excretion on High-Density Lipoprotein Cholesterol and Chronic Disease Risk in Chinese Adults: A Health Promotion Study

  2024cites this paper
• Associations of serum uric acid-to-high density lipoprotein cholesterol ratio with age-related diseases and mortality among older population in the United States.

  2024cites this paper
• Competition between enzymatic and non-enzymatic electrochemical determination of cholesterol

  2023cites this paper
• Blood biochemical changes upon subclinical intramammary infection and inflammation in Holstein cattle.

  2023cites this paper
• The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy

  2022influential citation
• Predictors of blood glucose change and microvascular complications of type 2 diabetes mellitus patients in Felege Hiwot and Debre Markos referral hospital, North West Ethiopia

  2022cites this paper
• Incidence and Predictors of Chronic Kidney Disease among Diabetes Mellitus Patients: A Retrospective Follow-Up Study at a Tertiary Health-Care Setting of Ethiopia

  2021cites this paper
• Association between functional neurometry test results and blood biomarkers indicative of anaemia, subclinical inflammation, and endothelial dysfunction

  2021cites this paper
• Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma

  2020cites this paper
• Incidence of Chronic Kidney Disease and Its Association with Fasting Blood Sugar Change Among Diabetic Patients in Resource Limited Setting in Case of Ethiopia: Bayesian Joint Modeling

  2020cites this paper
• Hemodynamics, baroreflex index and blood biomarkers of a patient who died after being affected by COVID-19: case report

  2020cites this paper
• Relation between resistin, PPAR-γ, obesity and atherosclerosis in male albino rats

  2020cites this paper
• Dyslipidemia in Type 1 Diabetes: A Masked Danger.

  2020cites this paper
• Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study

  2019cites this paper
• RELATIONSHIP BETWEEN PARAOXONASE-1 ACTIVITY AND LIPID MOBILISATION

  2019cites this paper
• Lipoproteins in Atherosclerosis Process.

  2019cites this paper
• Paraoxonase-1 activity and lipid profile in dairy cows with subclinical and clinical mastitis

  2018cites this paper
• Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study

  2018cites this paper
• Retinal vascular function in asymptomatic individuals with a positive family history of cardiovascular disease

  2018cites this paper
• Low Levels of High-Density Lipoprotein Cholesterol Are Independently Associated With Acute Coronary Heart Disease in Patients Hospitalized for Chest Pain

  2017cites this paper
• Efecto del ciprofibrato sobre el metabolismo del colesterol HDL y la capacidad antioxidante plasmática en el ratón

  2016cites this paper
• Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans

  2016cites this paper
• Relationship between paraoxonase-1 activity and lipid mobilisation in transition dairy cows.

  2016cites this paper
• High pentraxin 3 expression in aorta of patients with atherosclerosis and its correlation with other risk factors

  2016cites this paper
• Original Article High pentraxin 3 expression in aorta of patients with atherosclerosis and its correlation with other risk factors

  2016cites this paper
• Combining Rosuvastatin With Angiotensin-Receptor Blockers of Different PPARγ-Activating Capacity

  2015cites this paper
• Alcohol-independent beneficial cardiometabolic profile of individuals with hyper-HDL cholesterolemia in Japanese men and women.

  2015cites this paper
• [Familial hypertriglyceridemia: biochemical, clinical and molecular study in a Moroccan family].

  2015cites this paper
• Dietary Almonds Increase Serum HDL Cholesterol in Coronary Artery Disease Patients in a Randomized Controlled Trial.

  2015cites this paper
• Network-Based Analysis on Orthogonal Separation of Human Plasma Uncovers Distinct High Density Lipoprotein Complexes.

  2015cites this paper
• High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.

  2014cites this paper
• Genes associated with low serum high-density lipoprotein cholesterol.

  2014cites this paper
• Lipid-Modulating Treatments for Mixed Dyslipidemia Increase HDL-Associated Phospholipase A2 Activity with Differential Effects on HDL Subfractions

  2013cites this paper
• High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals

  2013cites this paper
• Etude de la capacité d'inhibition de l'apolipoprotéine C1 sur l'activité de la protéine de transfert des esters de cholestérol chez des patients coronariens normolipidémiques et hyperlipidémiques et chez des patients diabétiques

  2013cites this paper
• Long‐term high density lipoprotein infusion ameliorates metabolic phenotypes of diabetic db/db mice

  2013cites this paper
• HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism

  2013cites this paper
• Parámetros lipídicos y objetivos terapéuticos

  2012cites this paper
• Plant‐Derived Manufacturing of Apolipoprotein AIMilano: Purification and Functional Characterization

  2012cites this paper
• Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain.

  2012cites this paper
• A network-based approach to associate High Density Lipoprotein (HDL)''s subspeciation with its cardiovascular protective functions

  2012cites this paper
• Effects of Intravascular Laser Irradiation of Blood in Mitochondria Dysfunction and Oxidative Stress in Adults with Chronic Spinal Cord Injury

  2012cites this paper
• The Acute Effect of Endurance Exercise on Lipoproteins Measured by Nuclear Magnetic Resonance (NMR) in Healthy Men

  2012cites this paper
• Cardioprotective and hepatoprotective effects of natural products in metabolic syndrome

  2012cites this paper
• Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain.

  2012cites this paper
• Health benefits of high-density lipoproteins in preventing cardiovascular diseases.

  2012cites this paper
• 3 Lipid Disorders in Type 1 Diabetes

  2012cites this paper
• Effects of exercise intensity on HDL-C subparticles and atherogenic index.

  2011cites this paper
• Lipid status, paraoxonase-1 activity and metabolic parameters in serum of heifers and lactating cows related to oxidative stress.

  2011cites this paper
• High Density Lipoprotein (HDL) Promotes Glucose Uptake in Adipocytes and Glycogen Synthesis in Muscle Cells

  2011cites this paper
• Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.

  2011cites this paper
• Synthesis, characterization and in vitro hydrolysis of a gemfibrozil-nicotinic acid codrug for improvement of lipid profile.

  2011cites this paper
• Genetic Disorders of the Lipoprotein Metabolism; Diagnosis and Management

  2011cites this paper
• Milk Lipids | Cholesterol: Factors Determining Levels in Blood

  2011cites this paper
• Comprehensive Lipid Profiling Beyond LDL

  2011cites this paper
• Effects of novel chloroquine formulation on blood glucose concentration, renal and cardiovascular function in experimental animal paradigms.

  2011cites this paper
• Dairy Cows:: Nutrition, Fertility and Milk Production

  2011cites this paper
• Effects of sterol structure on insect herbivore physiology, biochemistry and molecular biology

  2011cites this paper
• Associations of Cholesterol and Glucose with Cardiovascular Dysfunction in Black Africans: The SABPA Study

  2011cites this paper
• Milk Lipids: Cholesterol: Factors Determining Levels in Blood

  2011cites this paper
• Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size.

  2010cites this paper
• Changes in Cognition and Amyloid-β Processing with Long Term Cholesterol Reduction using Atorvastatin in Aged Dogs

  2010cites this paper
• [Health state of the citizens of northern Kosovska Mitrovica].

  2010cites this paper
• Thematic Review Series: Genetics of Human Lipid Diseases Genetic causes of high and low serum HDL-cholesterol

  2010cites this paper
• Dysfunctional High-Density Lipoprotein and Atherosclerosis

  2010cites this paper
• Serum resistin levels and haemostatic changes in experimentally induced diabetic and high fat fed rats

  2010cites this paper
• NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations.

  2009cites this paper
• Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia

  2009influential citation
• Is myeloperoxidase a useful marker to predict the risk of cardiovascular events?

  2009cites this paper
• Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptides.

  2009cites this paper
• The association of 83 plasma proteins with CHD mortality, BMI, HDL-, and total-cholesterol in men: applying multivariate statistics to identify proteins with prognostic value and biological relevance.

  2009cites this paper
• Lipid modification in type 2 diabetes: the role of LDL and HDL

  2009cites this paper
• patient-oriented and epidemiological research Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes

  2009cites this paper
• Prenatal Exposure to Cigarette Smoke Induces Diet- and Sex-Dependent Dyslipidemia and Weight Gain in Adult Murine Offspring

  2009influential citation
• Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors.

  2009cites this paper
• Lipid disorders in type 1 diabetes.

  2009cites this paper
• HDL Metabolism and CETP Inhibition

  2008cites this paper
• The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

  2008cites this paper
• High density lipoprotein cholesterol and statin trials.

  2008cites this paper
• Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

  2008cites this paper
• Multiple actions of high-density lipoprotein

  2008cites this paper
• Vaccines in Development to Prevent and Treat Atherosclerotic Disease

  2008cites this paper
• Human cholesterol metabolism and therapeutic molecules

  2007cites this paper
• Long-Term Efficacy and Safety of First-Line Therapy with Once-Daily Saquinavir/Ritonavir

  2007cites this paper
• eCommons@AKU eCommons@AKU

  year unknowncites this paper